Old Web
English
Sign In
Acemap
>
authorDetail
>
Marc Lorber
Marc Lorber
Novartis
Internal medicine
Medicine
Anesthesia
Hepatitis C virus
Anemia
2
Papers
29
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
EFFECT OF ESUBERAPROST ON MORBIDITY AND MORTALITY IN WORLD HEALTH ORGANIZATION (WHO) FUNCTIONAL CLASS III AND IV (FC III/IV) PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: RESULTS FROM THE RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED PHASE 3 TRIAL- BERAPROST-314D ADDED TO TYVASO (BEAT)
2019
Chest
Ronald J. Oudiz
Mordechai R. Kramer
Sonja Bartolome
Robert C. Bourge
Hubert J. Ford
Boris I. Medarov
Jeffrey Sager
Shelley Shapiro
Aaron B. Waxman
David Ishizawar
Rajan Saggar
Robert Naeije
Jordan T. Shin
Prakash Sista
Aimee Smart
Michael Di Marino
Mary Lou Tomson
Marc Lorber
Show All
Source
Cite
Save
Citations (0)
HCV response in patients with end stage renal disease treated with combination pegylated interferon α-2a and ribavirin
2009
Journal of Clinical Gastroenterology
Wyel Hakim
Shehzad Z. Sheikh
Irteza Inayat
Cary Caldwell
Douglas Smith
Marc Lorber
Amy L. Friedman
Dhanpat Jain
Margaret J. Bia
Richard N. Formica
Wajahat Z. Mehal
Show All
Source
Cite
Save
Citations (29)
1